Sitaz – Glenmark Pharmaceuticals

Opposed App ID 5263279 Class 5 Word

Trademark information

IP India · live record
Application ID
5263279
Status
Opposed
Sub status
Not Applicable
Date of application
27 December 2021
Classes
5
Type
Word
Proprietor
Glenmark Pharmaceuticals Public B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026
Attorney
Vishesh And Associates[10756]301/302, A Wing, 3 Rd Floor, Shaheen Chambers, Dawood Baug, Opp. Pearl Heritage,Andheri (West), Mumbai 400 058.
State
Maharashtra
Filing mode
e-Filing
IP office
Mumbai
Used since
—
Valid / upto
—

Goods & services

Class 5

Class 5PHARMACEUTICAL AND MEDICINAL PREPARATIONS AND SUBSTANCES, DIETETIC FOOD AND SUBSTANCES ADAPTED FOR MEDICAL USE, DIETARY SUPPLEMENTS FOR HUMANS, NUTRITIONAL SUPPLEMENTS, NUTRACEUTICAL PREPARATIONS FOR THERAPEUTIC OR MEDICAL PURPOSES, NUTRACEUTICALS FOR USE AS DIETARY SUPPLEMENTS

Uploaded documents

Sign in to open
1 TM-A(TRADE MARKS APPLICATION) 27 Dec 2021
2 Journal Copy 20 Apr 2022
3 TM-O(NOTICE OF OPPOSITION) 06 Jun 2022
4 TM-O(NOTICE OF OPPOSITION) 07 Jun 2022
5 TM-M(REQUEST FOR PAYMENT OF MISC. FEE FOR OTHER PURPOSE) 31 Jan 2026
6 TM-M(REQUEST FOR PAYMENT OF MISC. FEE FOR OTHER PURPOSE) 31 Jan 2026

Correspondence and notices

1 Opposition Counter Statement 14617124 · 5823021 10 Jan 2023
2 Opposition Notice 14617135 · 5823024 10 Jan 2023
3 Opposition Counter Statement 14617165 · 5823032 10 Jan 2023
4 Opposition Notice 14617183 · 5823037 10 Jan 2023
5 Hearing Notice 21552281 · 7566689 12 Jan 2026
6 Hearing Notice 21552289 · 7566692 12 Jan 2026
7 General Order 21733876 · 7605682 04 Feb 2026
8 Opposition Counter Statement 21733882 · 7605683 04 Feb 2026
9 General Order 21733933 · 7605708 04 Feb 2026
10 Opposition Counter Statement 21733939 · 7605709 04 Feb 2026

Frequently asked questions

Sitaz was applied for on 27 December 2021.

The application was filed by Glenmark Pharmaceuticals.

Class 5.

As per IP India, the status is Opposed.

The listed application ID of Sitaz is 5263279.

Trademark attorney Vishesh And Associates.